Publications by authors named "Giulia Amadio"

Claim this Profile
R
Relationships between subendocardial perfusion impairment, arterial stiffness and orthostatic hypotension in hospitalized elderly individuals.
Francesco Fantin, Anna Giani, Federica Macchi, Giulia Amadio, Andrea P Rossi

J Hypertens· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Retinoblastoma Protein Family (Rb/p105 and Rb2/p130) Expression in the Histopathological Classification of Borderline Ovarian Tumors.
Valeria Masciullo, Paola Valdivieso, Giulia Amadio, Angela Santoro, Giuseppe Angelico

Front Med (Lausanne)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience.
Giulia Amadio, Claudia Marchetti, Emanuele Rocco Villani, Domenico Fusco, Francesca Stollagli

J Gynecol Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
Sandro Pignata, Giovanni Scambia, Domenica Lorusso, Ugo De Giorgi, Maria Ornella Nicoletto, Giulia Amadio

Gynecol Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment.
Gabriella Ferrandina, Giulia Amadio, Andrea Marcellusi, Elena Azzolini, Anna Puggina

Clin Drug Investig· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National Survey.
Gabriella Ferrandina, Giulia Amadio, Ida Paris, Mariagrazia Distefano, Eleonora Palluzzi

Int J Gynecol Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study.
Marco Petrillo, Ida Paris, Giuseppe Vizzielli, Giulia Amadio, Francesco Cosentino

Ann Surg Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging drugs for endometrial cancer.
Giulia Amadio, Valeria Masciullo, Maria Gabriella Ferrandina, Giovanni Scambia

Expert Opin Emerg Drugs· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the scope of practice and training of obstetricians and gynaecologists in England, Italy and Belgium: a qualitative study.
Isabelle Risso-Gill, Regine Kiasuwa, Rita Baeten, Ilenia Caldarelli, Silva Mitro, Giulia Amadio

Eur J Obstet Gynecol Reprod Biol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence.
Floriana Mascilini, Giulia Amadio, Maria Grazia Di Stefano, Manuela Ludovisi, Alessia Di Legge

Onco Targets Ther· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on the pharmacotherapy for endometrial cancer.
Giulia Amadio, Valeria Masciullo, Letizia Stefano, Giovanni Scambia

Expert Opin Pharmacother· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: a retrospective, multicenter study.
Gabriella Ferrandina, Vanda Salutari, Bruno Vincenzi, Marco Marinaccio, Emanuele Naglieri, Giulia Amadio

Gynecol Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversy in treatment of advanced ovarian cancer.
Giovanni Scambia, Vanda Salutari, Giulia Amadio

Lancet Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging drugs for ovarian cancer.
Domenica Lorusso, Antonella Pietragalla, Sara Mainenti, Alessia Di Legge, Giulia Amadio

Expert Opin Emerg Drugs· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of cervical cancer in Italy: strategies and their impact on the women.
Rosa De Vincenzo, Giulia Amadio, Caterina Ricci, Angelo Licameli, Gabriella Ferrandina

Vaccine· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis